Literature DB >> 30254515

SUDEP: When the Nightmare Becomes the Reality.

Katherine C Nickels.   

Abstract

Year:  2018        PMID： 30254515      PMCID： PMC6145388          DOI： 10.5698/1535-7597.18.4.227

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  13 in total

1.  Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials.

Authors:  Philippe Ryvlin; Michel Cucherat; Sylvain Rheims
Journal:  Lancet Neurol       Date:  2011-09-19       Impact factor: 44.182

2.  Combined analysis of risk factors for SUDEP.

Authors:  Dale C Hesdorffer; Torbjorn Tomson; Emma Benn; Josemir W Sander; Lena Nilsson; Yvonne Langan; Thaddeus S Walczak; Ettore Beghi; Martin J Brodie; Allen Hauser
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

3.  Electrocardiographic and oximetric changes during partial complex and generalized seizures.

Authors:  Brian D Moseley; Elaine C Wirrell; Katherine Nickels; Jonathan N Johnson; Michael J Ackerman; Jeffrey Britton
Journal:  Epilepsy Res       Date:  2011-05-10       Impact factor: 3.045

Review 4.  National Association of Medical Examiners position paper: Recommendations for the investigation and certification of deaths in people with epilepsy.

Authors:  Owen Middleton; Daniel Atherton; Elizabeth Bundock; Elizabeth Donner; Daniel Friedman; Dale Hesdorffer; Heather Jarrell; Aileen McCrillis; Othon J Mena; Mitchel Morey; David Thurman; Niu Tian; Torbjörn Tomson; Zian Tseng; Steven White; Cyndi Wright; Orrin Devinsky
Journal:  Epilepsia       Date:  2018-03-01       Impact factor: 5.864

5.  Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Cynthia Harden; Torbjörn Tomson; David Gloss; Jeffrey Buchhalter; J Helen Cross; Elizabeth Donner; Jacqueline A French; Anthony Gil-Nagel; Dale C Hesdorffer; W Henry Smithson; Mark C Spitz; Thaddeus S Walczak; Josemir W Sander; Philippe Ryvlin
Journal:  Neurology       Date:  2017-04-25       Impact factor: 9.910

Review 6.  Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention.

Authors:  Orrin Devinsky; Dale C Hesdorffer; David J Thurman; Samden Lhatoo; George Richerson
Journal:  Lancet Neurol       Date:  2016-08-08       Impact factor: 44.182

Review 7.  Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  George L Morris; David Gloss; Jeffrey Buchhalter; Kenneth J Mack; Katherine Nickels; Cynthia Harden
Journal:  Neurology       Date:  2013-08-28       Impact factor: 9.910

8.  Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy.

Authors:  Philippe Ryvlin; Elson L So; Charles M Gordon; Dale C Hesdorffer; Michael R Sperling; Orrin Devinsky; Mark T Bunker; Bryan Olin; Daniel Friedman
Journal:  Epilepsia       Date:  2018-01-16       Impact factor: 5.864

9.  The incidence and significance of periictal apnea in epileptic seizures.

Authors:  Nuria Lacuey; Bilal Zonjy; Johnson P Hampson; M R Sandhya Rani; Anita Zaremba; Rup K Sainju; Brian K Gehlbach; Stephan Schuele; Daniel Friedman; Orrin Devinsky; Maromi Nei; Ronald M Harper; Luke Allen; Beate Diehl; John J Millichap; Lisa Bateman; Mark A Granner; Deidre N Dragon; George B Richerson; Samden D Lhatoo
Journal:  Epilepsia       Date:  2018-01-16       Impact factor: 5.864

10.  Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation.

Authors:  Orrin Devinsky; Daniel Friedman; Robert B Duckrow; Nathan B Fountain; Ryder P Gwinn; James W Leiphart; Anthony M Murro; Paul C Van Ness
Journal:  Epilepsia       Date:  2018-01-16       Impact factor: 5.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.